Aimed Alliance Releases Biomarker Testing Fact Sheet
On June 2, 2022, Aimed Alliance released a new fact sheet on biomarker testing titled “Increase Access to Precision Medicine…
Browsing: Aimed Activity
Conversation with Aimed Alliance Featured in Patient Empowerment Network Activity Guide on Health Policy
Aimed Alliance’s staff attorney, Ashira Vantrees, spoke with the Patient Empowerment Network for their May 2022 Activity Guide on “How…
FDA Sends Warning Letters to Four Companies for Selling Unapproved CBD Products
On May 26, the Food and Drug Administration (FDA) sent warning letters to Free State Oils, Kingdom Harvest, Kahm CBD,…
Report Examines Consequences of Non-Medical Switching for Patients with Mental Health Conditions
A new report from the Alliance for Mental Health Care Access entitled The Dangers of Non-Medical Switching for Mental Health…
New Study Provides Information on the Impact of CBD on Consumer’s Health
In March 2020, the U.S. Food and Drug Administration (FDA) recognized the need for more data to address the gaps…
CCSS Sends Letter of Support for Dietary Supplement Listing Act of 2022
On May 18, the Collaborative for Cannabinoid Science and Safety (CCSS) sent a letter to U.S. Senators Durbin and Braun…
Aimed Alliance summarizes Johnson & Johnson’s lawsuit against SaveOnSP
On May 4, 2022, Johnson & Johnson filed a complaint in the United States District Court of New Jersey against…
Aimed Alliance adds FAQ to Copay Accumulator 101 Hub
On May 15, 2022, Aimed Alliance updated its Copay Accumulator 101 Hub to include a Frequently Asked Questions (FAQ) section.…
Aimed Alliance Releases New Maps on Biomarker Testing
On May 10, 2022, Aimed Alliance launched two new maps to track active and enacted biomarker legislation. Biomarker testing can…
Aimed Alliance Speaks at HealthyWomen’s Cures 2.0 Virtual Policy Discussion
On May 11, 2022, Aimed Alliance’s staff attorney, Ashira Vantrees, participated as a panelist on Healthy Women’s Virtual Policy Discussion…